In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SMT Research and Development Ltd.

www.smtmed.com

Latest From SMT Research and Development Ltd.

TCT 2018: Next-Gen Stents, Key Insights From Leading Experts

The Transcatheter Cardiovascular Therapeutics meeting held in San Diego featured late-breaking trials of new stent technologiesincluding TALENT, BIONYX, BIOFLOW-V, SORT-OUT IX, LEADERS FREE II and ReCre8.

Commercial Clinical Trials

Top Device Stories Of 2011: Living In A State Of Transition

EBI’s device team reviews of the top news stories in the medical device industry in 2011. Top stories include: 510(k) reform, user-fees, VC money dries up for medtech, hot clinical spaces of the year, where private investment dollars went in 2011, big changes at J&J, and the new physician/hospital alignments and their impact on the medical device industry.

Medical Device Business Strategies

Emboline Inc.

While the focus of aortic embolic protection has previously been limited to stroke prevention, Emboline Inc. believes the concern should be broader because there are other complications that can be caused by emboli moving downstream, resulting in diminished function or failure of other organs, such as the kidneys. The company’s Emboline CAP device provides complete protection of the arterial system from these emboli, thanks to a central filter enabled by an access port that allows for tool access through the filter.

Medical Device

As TAVI Advances, Adjunctive Devices Multiply

As researchers work to more fully understand the risks and durability of transcatheter aortic heart valve implantation (TAVI) procedures, device innovators are already attempting to engineer solutions to some of the more obvious areas of unmet need.

As researchers work to more fully understand the risks and durability of transcatheter aortic heart valve implantation (TAVI) procedures, device innovators are already attempting to engineer solutions to some of the more obvious areas of unmet need.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • SMT Research and Development Ltd.
  • Senior Management
  • Paul J Zalesky, PhD, CEO
    Dov Shimon, MD, Pres. & CMO
  • Contact Info
  • SMT Research and Development Ltd.
    Phone: 99508089
    20 Galgaley Haplada St.
    Herzliya Pituac
    Herzliya, 46722
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register